To investigate the predictive value of CTLA4 DNA methylation, we analyzed CTLA4 DNA methylation levels in our cohort of patients with advanced or metastatic HNSCC prior to ICB. The gene discussed is CTLA4; the disease is head and neck squamous cell carcinoma.